Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Deutsche Rohstoff AG: A reportable insider transaction was published on 23rd April 2025. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 23rd April 2025,
The Insider Transaction was made by Zöllner, Dr. Werner 
. The transaction toke place on 17th April 2025. . The aggregated volume was 100.000,00 EUR, based on an average price of 1.030,00 EUR. The nature of the Investment was not specified.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 18th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th February 2025,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 17th February 2025. The order was executed at the trading place Xetra. . The aggregated volume was 12.014,56 EUR, based on an average price of 8,56 EUR. The nature of the Investment was Buy.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 17th February 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th February 2025,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 14th February 2025. The order was executed at the trading place XETRA. . The aggregated volume was 11.738,00 EUR, based on an average price of 8,70 EUR. The nature of the Investment was Buy.
HWA AG: A reportable insider transaction was published on 24th December 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 24th December 2024,
The Insider Transaction was made by Aufrecht, Hans Werner . The transaction toke place on 23rd December 2024. . The aggregated volume was 600.000,00 EUR, based on an average price of 2,40 EUR. The nature of the Investment was Sell.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 21st August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st August 2024,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 21st August 2024. The order was executed at the trading place Gettex. . The aggregated volume was 17.950,00 EUR, based on an average price of 8,97 EUR. The nature of the Investment was Buy.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 15th February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th February 2024,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 15th February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 10.272,66 EUR, based on an average price of 16,33 EUR. The nature of the Investment was Buy.
thyssenkrupp nucera AG & Co. KGaA: A reportable insider transaction was published on 14th February 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 14th February 2024,
The Insider Transaction was made by Ponikwar, Dr. Werner . The transaction toke place on 14th February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 13.529,00 EUR, based on an average price of 15,84 EUR. The nature of the Investment was Buy.
RWE Aktiengesellschaft: A reportable insider transaction was published on 8th February 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 8th February 2024,
The Insider Transaction was made by Brandt, Dr. Werner . The transaction toke place on 6th February 2024. The order was executed at the trading place Xetra. . The aggregated volume was 107.839,15 EUR, based on an average price of 32,68 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 28th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 28th December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 14th December 2023. The order was executed at the trading place XETRA. . The aggregated volume was 301.806,31 EUR, based on an average price of 20,12 EUR. The nature of the Investment was Sell.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 23rd October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 162.000,00 EUR, based on an average price of 16,20 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 20th October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 253.488,25 EUR, based on an average price of 16,90 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 13th October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 169.991,69 EUR, based on an average price of 17,00 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 5th October 2023. The order was executed at the trading place XETRA. . The aggregated volume was 174.067,78 EUR, based on an average price of 17,41 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 21st September 2023. The order was executed at the trading place XETRA. . The aggregated volume was 192.700,00 EUR, based on an average price of 19,27 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 21st August 2023. The order was executed at the trading place XETRA. . The aggregated volume was 199.999,04 EUR, based on an average price of 20,00 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 20th July 2023. The order was executed at the trading place XETRA. . The aggregated volume was 263.815,06 EUR, based on an average price of 23,81 EUR. The nature of the Investment was Sell.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 5th May 2023. The order was executed at the trading place XETRA. . The aggregated volume was 159.989,05 EUR, based on an average price of 16,00 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd December 2023,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 20th April 2023. The order was executed at the trading place XETRA. . The aggregated volume was 176.000,00 EUR, based on an average price of 17,60 EUR. The nature of the Investment was Buy.
Evotec SE: A reportable insider transaction was published on 22nd January 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 22nd January 2024,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 18th January 2024. . The aggregated volume was 397.543,19 EUR, based on an average price of 14,84 EUR. The nature of the Investment was Sell.
Evotec SE: A reportable insider transaction was published on 18th January 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th January 2024,
The Insider Transaction was made by Lanthaler, Dr. Werner . The transaction toke place on 16th January 2024. . The aggregated volume was 159.141,96 EUR, based on an average price of 15,49 EUR. The nature of the Investment was not specified.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.